Home Cart Sign in  
Chemical Structure| 1158279-20-9 Chemical Structure| 1158279-20-9

Structure of HLCL-61 HCl
CAS No.: 1158279-20-9

Chemical Structure| 1158279-20-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

HLCL-61 HCl is an inhibitor of PRMT5 that is used for the treatment of acute myeloid leukemia.

Synonyms: HLCL-61 (hydrochloride); HLCL61; HLCL-61 hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of HLCL-61 HCl

CAS No. :1158279-20-9
Formula : C23H25ClN2O
M.W : 380.91
SMILES Code : [H]Cl.COC1=CC=CC=C1CNCC2=CC3=C(C=C2)N(CC)C4=C3C=CC=C4
Synonyms :
HLCL-61 (hydrochloride); HLCL61; HLCL-61 hydrochloride
MDL No. :MFCD09446681
InChI Key :XYAVCNMZZKTEGR-UHFFFAOYSA-N
Pubchem ID :17208222

Safety of HLCL-61 HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of HLCL-61 HCl

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SNU-449 40 μM 48 hours HLCL-61 inhibits PRMT5 activity and blocks the interaction between LINC01138 and PRMT5 PMC5910401
C4-2B cells 1 μM 5 days Inhibited cell proliferation, IC50 0.4 mM PMC6191320
AML primary blasts 3.98–8.72 μM 24-72 hours Evaluate the inhibitory effect of HLCL-61 on the growth of AML primary blasts, results showed that HLCL-61 significantly inhibited the growth of AML primary blasts. PMC8034866
LNCaP-EnzR cells 1 μM 5 days To evaluate the effect of EPZ-6438 on enzalutamide-resistant cells, results showed that EPZ-6438 could enhance the sensitivity to enzalutamide PMC6191320
LNCaP cells 1 μM 5 days To evaluate the effect of JNJ-64619178 on DNA damage repair, results showed JNJ-64619178 significantly inhibited DNA damage repair PMC6191320
SMMC-7721 40 μM 48 hours SNS-314 significantly inhibited the proliferation of SMMC-7721 cells in a dose-dependent manner. PMC5910401
Acute myeloid leukemia cell line 7.21-21.46 µM 16 hours Evaluate the inhibitory effect of HLCL-61 on acute myeloid leukemia cell line PMC6375878
THP-1 cells 7.21–21.46 μM 24-72 hours Assess migration capability of THP-1 cells PMC8034866
MV4-11 cells 7.21–21.46 μM 24-72 hours Evaluate the inhibitory effect of PLX51107 on FLT3-ITD mutated AML cells PMC8034866

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.63mL

0.53mL

0.26mL

13.13mL

2.63mL

1.31mL

26.25mL

5.25mL

2.63mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories